To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1989
To demonstrate the relative bioequivalency study of dosage forms of Clemastine 2.68 mg tablets.
Epistemonikos ID: 39029ba29b95ab8c598fdc18cf5a924dafe750f7
First added on: May 05, 2024